Shares of Afya Limited (NASDAQ:AFYA – Get Free Report) saw strong trading volume on Thursday . Approximately 249,783 shares changed hands during mid-day trading, an increase of 127% from the previous session’s volume of 110,208 shares.The stock last traded at $14.9780 and had previously closed at $14.91.
Analyst Ratings Changes
A number of equities analysts have issued reports on AFYA shares. Wall Street Zen lowered Afya from a “buy” rating to a “hold” rating in a research note on Saturday, August 15th. Zacks Research downgraded shares of Afya from a “hold” rating to a “strong sell” rating in a research note on Friday, August 21st. Bank of America reaffirmed a “neutral” rating on shares of Afya in a report on Thursday, June 11th. JPMorgan Chase & Co. decreased their target price on Afya from $21.50 to $21.00 and set a “neutral” rating for the company in a research report on Monday, June 22nd. Finally, Weiss Ratings downgraded shares of Afya from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, July 31st. Five analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce” and an average target price of $18.00.
Read Our Latest Research Report on Afya
Afya Price Performance
Afya (NASDAQ:AFYA – Get Free Report) last issued its quarterly earnings data on Friday, August 14th. The company reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.03. The firm had revenue of $187.80 million during the quarter, compared to the consensus estimate of $189.62 million. Afya had a return on equity of 17.58% and a net margin of 20.55%. On average, analysts expect that Afya Limited will post 1.84 earnings per share for the current year.
Insider Transactions at Afya
In related news, VP Lelio De Souza Junior sold 41,541 shares of the company’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $15.00, for a total transaction of $623,115.00. Following the sale, the vice president owned 36,204 shares in the company, valued at $543,060. This represents a 53.43% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Gomiero Mirella Basolli sold 10,000 shares of the firm’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $14.80, for a total value of $148,000.00. Following the completion of the sale, the vice president directly owned 34,530 shares in the company, valued at $511,044. The trade was a 22.46% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 87,745 shares of company stock worth $1,314,175 over the last 90 days. Insiders own 0.80% of the company’s stock.
Institutional Investors Weigh In On Afya
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Swedbank AB increased its holdings in Afya by 170.3% in the fourth quarter. Swedbank AB now owns 189,200 shares of the company’s stock worth $2,916,000 after buying an additional 119,200 shares during the last quarter. Fairtree Asset Management Pty Ltd boosted its holdings in shares of Afya by 22.3% in the 4th quarter. Fairtree Asset Management Pty Ltd now owns 30,697 shares of the company’s stock worth $473,000 after purchasing an additional 5,599 shares during the period. Pictet Asset Management Holding SA acquired a new stake in Afya in the fourth quarter valued at approximately $508,000. Mangrove Partners IM LLC acquired a new position in Afya in the fourth quarter valued at $197,000. Finally, Squarepoint Ops LLC acquired a new stake in Afya during the third quarter valued at $191,000. 88.02% of the stock is currently owned by institutional investors.
About Afya
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Featured Stories
- Five stocks we like better than Afya
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
- One of Trump’s Favorite Stocks Just Reported Blowout Earnings
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
